ID   CT26.WT
AC   CVCL_7256
SY   CT-26 WT; CT26.wt; CT26WT
DR   BTO; BTO:0006018
DR   CLO; CLO_0002631
DR   ATCC; CRL-2638
DR   BCRC; 60447
DR   BCRJ; 0402
DR   BioSample; SAMN11397649
DR   CCRID; 1101MOU-PUMC000275
DR   CCRID; 3101MOUTCM37
DR   ChEMBL-Cells; CHEMBL4513106
DR   ChEMBL-Targets; CHEMBL4513123
DR   CLS; 305178
DR   PubChem_Cell_line; CVCL_7256
DR   Ubigene; YC-B003
DR   Wikidata; Q54814710
RX   DOI=10.21926/obm.genet.1803037;
RX   PubMed=7722321;
RX   PubMed=11089883;
RX   PubMed=24621249;
RX   PubMed=25277546;
RX   PubMed=31220119;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=24621249).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (PubMed=24621249).
CC   Transformant: ChEBI; CHEBI:82373; N-nitroso-N-methylurethane (NNMU).
CC   Omics: Array-based CGH.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119; Ubigene
ST   Mouse STR 1-1: 14,15
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2,17.2,18.2
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 19,20
ST   Mouse STR 19-2: 13
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR X-1: 25,26
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
RX   DOI=10.21926/obm.genet.1803037;
RA   Rhode H., Liehr T., Kosyakova N., Rincic M., Hussein Azawi S.S.;
RT   "Molecular cytogenetic characterization of two murine colorectal cancer cell
RT   lines.";
RL   OBM Genetics 2:1803037.1-1803037.24(2018).
//
RX   PubMed=7722321; DOI=10.4049/jimmunol.154.9.4685;
RA   Wang M., Bronte V., Chen P.W., Gritz L., Panicali D., Rosenberg S.A.,
RA   Restifo N.P.;
RT   "Active immunotherapy of cancer with a nonreplicating recombinant
RT   fowlpox virus encoding a model tumor-associated antigen.";
RL   J. Immunol. 154:4685-4692(1995).
//
RX   PubMed=11089883; DOI=10.1023/A:1006730320248;
RA   Ikubo A., Aoki Y., Nagai E., Suzuki T.;
RT   "Highly metastatic variant of a mouse colon carcinoma cell line, LM17
RT   and its response to GM-CSF gene therapy.";
RL   Clin. Exp. Metastasis 17:849-855(1999).
//
RX   PubMed=24621249; DOI=10.1186/1471-2164-15-190;
RA   Castle J.C., Loewer M., Boegel S., de Graaf J., Bender C.,
RA   Tadmor A.D., Boisguerin V., Bukur T., Sorn P., Paret C., Diken M.,
RA   Kreiter S., Tureci O., Sahin U.;
RT   "Immunomic, genomic and transcriptomic characterization of CT26
RT   colorectal carcinoma.";
RL   BMC Genomics 15:190.1-190.12(2014).
//
RX   PubMed=25277546; DOI=10.1186/1471-2164-15-847;
RA   Didion J.P., Buus R.J., Naghashfar Z., Threadgill D.W.,
RA   Morse H.C. III, Pardo-Manuel de Villena F.;
RT   "SNP array profiling of mouse cell lines identifies their strains of
RT   origin and reveals cross-contamination and widespread aneuploidy.";
RL   BMC Genomics 15:847.1-847.11(2014).
//
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B.A., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).
//